Correlation Between Pfizer and Cocrystal Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cocrystal Pharma, you can compare the effects of market volatilities on Pfizer and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cocrystal Pharma.

Diversification Opportunities for Pfizer and Cocrystal Pharma

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Cocrystal is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Pfizer i.e., Pfizer and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Pfizer and Cocrystal Pharma

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.12 times less risky than Cocrystal Pharma. The stock trades about -0.08 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  244.00  in Cocrystal Pharma on September 4, 2024 and sell it today you would lose (37.00) from holding Cocrystal Pharma or give up 15.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Pfizer Inc  vs.  Cocrystal Pharma

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Cocrystal Pharma 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Cocrystal Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Cocrystal Pharma

The main advantage of trading using opposite Pfizer and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.
The idea behind Pfizer Inc and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity